Therefore, our and previous studies suggest that the pathogenesis of PAH may be more complicated in female than male PAH patients, and that the influence of BMPR2 mutations may be modified by additional unknown factors in female patients. This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.